aid: myra-vision
name: Myra Vision
description: 'Myra Vision, Inc. is a clinical-stage ophthalmic medical device company
  headquartered in Campbell, California, and a privately held portfolio company of
  the Shifamed LLC medical device incubator. It develops the Calibreye Titratable Glaucoma
  Therapy (TGT) Surgical System, an aqueous shunt for patients with moderate to severe
  glaucoma whose valve-controlled outflow channels use shape-memory nitinol and can
  be reversibly opened or closed in-office with a transcorneal laser, letting a clinician
  titrate intraocular pressure after implantation rather than committing to a fixed
  flow at the time of surgery. The company completed first-in-human use of the Calibreye
  System in 2023, received FDA conditional approval of its Investigational Device Exemption
  in August 2025, and enrolled the first patient in its US ADAPT clinical study in
  January 2026. As a medical device manufacturer its product is a physical implant
  and a surgical procedure, not software: Myra Vision publishes no public developer
  API, SDK, developer portal, or machine-readable API specification, and this profile
  captures its corporate identity and public web properties in the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/myra-vision/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Medical Devices
- Healthcare
- Ophthalmology
- Glaucoma
- Life Sciences
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/myra-vision-domain-security.yml
- type: Website
  url: https://www.myravision.com/
- type: PrivacyPolicy
  url: https://www.myravision.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/myra-vision
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Myra Vision is a 25-person clinical-stage medical device maker whose product is
    the Calibreye titratable glaucoma shunt — a nitinol implant adjusted in-office by
    laser, not software; its entire web presence is a five-page WordPress marketing
    site (home, sign-up, privacy policy, titratable-outflow, 404) with no developer,
    docs, or api subdomain resolving in DNS, no GitHub organization, and no package on
    npm/PyPI, and the origin additionally answers every path with a SiteGround captcha
    challenge (HTTP 202) so live /.well-known and /openapi.json probes were confirmed
    against archived crawls instead.
  evidence:
  - url: https://www.myravision.com/
    status: 202
  - url: https://www.myravision.com/openapi.json
    status: 202
  - url: https://web.archive.org/web/20250305100237id_/https://www.myravision.com/page-sitemap.xml
    status: 200
  - url: https://web.archive.org/web/20250306013206/https://www.myravision.com/.well-known/security.txt
    status: 404
  - url: https://api.github.com/orgs/myravision
    status: 404
  checked: '2026-08-04'